Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

IBRN ETF Forecast & Price Targets

Compare
See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

IBRN Analyst Ratings

Moderate Buy
66ConsensusRatings
53Buy13Hold0Sell
Based on the Wall Street analyst consensus for 66 of IBRN’s holdings.

IBRN 12 Month Forecast

$54.10▲(75.71% Upside)
Based on Wall Street analyst 12-month price targets for 66 of iShares Neuroscience and Healthcare ETF’s holdings in the last 3 months. The average price target is $54.10 with a high forecast of $71.71 and a low forecast of $38.49. The average price target represents a 75.71% change from the last price of $30.79.
Highest Price Target$71.71Average Price Target$54.10Lowest Price Target$38.49

IBRN Stocks With Highest Upside Potential

IBRN highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Strong Buy$5.25(1017.02% Upside)
Strong Buy$16.33(670.44% Upside)
Strong Buy$13.75(570.73% Upside)
Strong Buy$38.00(563.18% Upside)
Moderate Buy$10.00(549.35% Upside)

IBRN Stocks With Highest Downside Potential

IBRN highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Moderate Buy$241.83(3.57% Upside)
Strong Buy$29.50(13.46% Upside)
Hold¥1,066.67(15.32% Upside)
Hold$16.00(18.96% Upside)
Moderate Buy€31.82(20.97% Upside)

IBRN ETF FAQ

What is IBRN’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 66 of IBRN’s holdings, iShares Neuroscience and Healthcare ETF’s 12-month average price target is $54.10.
What is IBRN’s upside potential, based on the analysts’ average price target?
IBRN’s average price target of $54.10 represents a 75.71% upside from its last price of $30.79.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IBRN a Buy, Sell or Hold?
iShares Neuroscience and Healthcare ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 66 of IBRN’s holdings: 53 rated Buy, 13 rated Hold and 0 rated Sell.
What is iShares Neuroscience and Healthcare ETF’s price target?
The average price target for iShares Neuroscience and Healthcare ETF is $54.10, based on Wall Street analyst 12-month price targets for 66 of IBRN’s holdings, issued in the past 3 months. The highest price target is $71.71 and the lowest is $38.49. The average price target represents a 75.71% increase from the last price of $30.79.
What do analysts say about iShares Neuroscience and Healthcare ETF?
iShares Neuroscience and Healthcare ETF’s analyst rating consensus is Moderate Buy, based on Wall Street analyst ratings for 66 of IBRN’s holdings.
How can I buy shares of IBRN?
You can buy shares of IBRN through a brokerage account. Compare brokers on our Best Online Brokers page.